Chandler Regional Medical Center

Chandler, Arizona 85297

4 studies enrolling now · 31 studies all time

What they study most

Acute Coronary Syndrome, Acute Coronary Syndrome (ACS), Acute Kidney Injury, Acute Myocardial Infarction, Aortic Valve Stenosis, Arterial Occlusive Diseases, Atrial Fibrillation, COVID-19, COVID-19 Infection, CPAP, Cardiovascular Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities

Studies at this site

• CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial — Recruiting now
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
• SELUTION4BTK Trial — Recruiting now
• A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions — Recruiting now
• HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial — Recruiting now
• Clinical Validation of the RENISCHEM L-FABP POC Assay — Completed
• A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes — Completed
• Randomized Study of the pdSTIM™ System in Failure to Wean Mechanically Ventilated Patients — Stopped early
• AMPLATZER PFO Occluder Post Approval Study — Running, not enrolling
• LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients — Completed
• Sleep for Stroke Management and Recovery Trial — Running, not enrolling
• Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ) — Stopped early
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications — Completed
• Infigratinib in Recurrent High-Grade Glioma Patients — Stopped early
• A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection — Completed
• Novel Experimental COVID-19 Therapies Affecting Host Response — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast) — Completed
• Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) — Running, not enrolling
• A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation — Stopped early
• Genetic Risk Stratification for Primary Prevention of CAD in Men and Pre & Post-menopausal Women — Status unconfirmed
• Absorb IV Randomized Controlled Trial — Completed
• Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19) — Completed
• Convalescent Plasma in Outpatients With COVID-19 — Completed
• Mild and Rapidly Improving Stroke Study — Completed
• Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW) — Status unconfirmed
• VITROS Immunodiagnostic Products hs Troponin I — Status unconfirmed
• Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter — Completed
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early
• Evaluation of a New Cardiac Biomarker Assay — Completed
• ADenosine Vasodilator Independent Stenosis Evaluation II - ADVISE II — Completed